These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9248560)

  • 21. Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice.
    Gadotti VM; Tibola D; Paszcuk AF; Rodrigues AL; Calixto JB; Santos AR
    Brain Res; 2006 Jun; 1093(1):116-22. PubMed ID: 16765330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Causes of pain investigated at molecular level.
    Benowitz S
    J Natl Cancer Inst; 2000 Jun; 92(11):868-70. PubMed ID: 10841819
    [No Abstract]   [Full Text] [Related]  

  • 23. Biochemical aspects of chronic pain and its relationship to treatment.
    Pleuvry BJ; Lauretti GR
    Pharmacol Ther; 1996; 71(3):313-24. PubMed ID: 8940746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis.
    Fairbanks CA; Stone LS; Wilcox GL
    Pharmacol Ther; 2009 Aug; 123(2):224-38. PubMed ID: 19393691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nociception in the spinal cord: mechanisms and therapeutic approaches.
    Collins JG
    Acta Anaesthesiol Scand Suppl; 1997; 111():180-1. PubMed ID: 9421003
    [No Abstract]   [Full Text] [Related]  

  • 26. [Control of pain].
    Ferri S
    Recenti Prog Med; 1985; 76(7-8):401-18. PubMed ID: 2866567
    [No Abstract]   [Full Text] [Related]  

  • 27. Combination spinal analgesic chemotherapy: a systematic review.
    Walker SM; Goudas LC; Cousins MJ; Carr DB
    Anesth Analg; 2002 Sep; 95(3):674-715. PubMed ID: 12198058
    [No Abstract]   [Full Text] [Related]  

  • 28. ST91 [2-(2,6-diethylphenylamino)-2-imidazoline hydrochloride]-mediated spinal antinociception and synergy with opioids persists in the absence of functional alpha-2A- or alpha-2C-adrenergic receptors.
    Stone LS; Kitto KF; Eisenach JC; Fairbanks CA; Wilcox GL
    J Pharmacol Exp Ther; 2007 Dec; 323(3):899-906. PubMed ID: 17855473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the role of spinal N-methyl-D-aspartate receptors in thermal nociception in the rat.
    Kolhekar R; Meller ST; Gebhart GF
    Neuroscience; 1993 Nov; 57(2):385-95. PubMed ID: 7906873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dextromethorphan and dexmedetomidine: new agents for the control of perioperative pain.
    Weinbroum AA; Ben-Abraham R
    Eur J Surg; 2001 Aug; 167(8):563-9. PubMed ID: 11716440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Non-opioid analgesics in cancer pain].
    Dohi S
    Nihon Rinsho; 2001 Sep; 59(9):1800-5. PubMed ID: 11554055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists.
    Aanonsen LM; Wilcox GL
    J Pharmacol Exp Ther; 1987 Oct; 243(1):9-19. PubMed ID: 2822907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mivazerol, a novel alpha2-agonist and potential anti-ischemic drug, inhibits KC1-stimulated neurotransmitter release in rat nervous tissue preparations.
    El Tamer A; Prokopenko I; Wülfert E; Hanin I
    J Neurochem; 1996 Aug; 67(2):636-44. PubMed ID: 8764590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additives in neuraxial anesthesia: opioids, alpha-2 adrenergic agonists, and neostigmine as a possible future drug for perioperative pain management.
    Klimscha W; Chiari A; Lorber C; Krenn K; Dumitrescu R; Agnese T
    Acta Anaesthesiol Scand Suppl; 1996; 109():176-8. PubMed ID: 8901999
    [No Abstract]   [Full Text] [Related]  

  • 35. Neonates have a spinal alpha receptor too, as do adults.
    Yaksh TL
    Br J Pharmacol; 2007 Aug; 151(8):1139-40. PubMed ID: 17641678
    [No Abstract]   [Full Text] [Related]  

  • 36. Intrathecal adenosine interacts with a spinal noradrenergic system to produce antinociception in nerve-injured rats.
    Gomes JA; Li X; Pan HL; Eisenach JC
    Anesthesiology; 1999 Oct; 91(4):1072-9. PubMed ID: 10519511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of spinal alpha-2 adrenoceptors, but not mu-opioid receptors, reduces the intrathecal N-methyl-D-aspartate-induced increase in spinal NR1 subunit phosphorylation and nociceptive behaviors in the rat.
    Roh DH; Seo HS; Yoon SY; Song S; Han HJ; Beitz AJ; Lee JH
    Anesth Analg; 2010 Feb; 110(2):622-9. PubMed ID: 20007733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of chronic pain of malignant origin with intrathecal opiates.
    Onofrio BM
    Clin Neurosurg; 1983; 31():304-15. PubMed ID: 6149833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spinal cord pharmacology of pain.
    Dickenson AH
    Br J Anaesth; 1995 Aug; 75(2):193-200. PubMed ID: 7577253
    [No Abstract]   [Full Text] [Related]  

  • 40. Spinal administration of receptor-selective drugs as analgesics: new horizons.
    Sosnowski M; Yaksh TL
    J Pain Symptom Manage; 1990 Jun; 5(3):204-13. PubMed ID: 2164072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.